DowDuPont revealed as leads in global CRISPR patents; study points to potential trouble ahead
Register to access two of our subscriber only articles per month.
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Author | Life sciences reporter
@IAM_Alerts Our 5G licensing rates will be ready before mass vehicle roll-out begins, says top @AvanciCompany executive, as the… https://t.co/bRjTXpR4Ho Read more
@IAM_Alerts RT @marconi: Last week, our @Avanci colleague Luke McLeroy spoke at @IAM_Alerts' #AutoIPUSA event in Detroit.
On Nov 2, Laurie Fitzgerald… Read more
@IAM_Alerts After a tough 2020 for med-tech deal-making, diagnostic innovation buyouts are driving a resurgence in IP-rich acqu… https://t.co/M44uKPtagj Read more
@IAM_Alerts Ericsson posts strong licensing quarter as it heads into an all-important renewal with Apple https://t.co/xbbxWFsscH https://t.co/KZpjln1pcM Read more